Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ferrous iron in the labile iron pool (LIP) represents a transient, chelatable, and redox-active fraction of intracellular iron that is not tightly bound to storage proteins like ferritin (Kakalij et al., 2015). This pool is primarily composed of Fe2+ ions associated with low-molecular-weight ligands such as citrate, ATP, or glutathione, making it readily available for metabolic processes but also potentially hazardous (Espósito et al., 2002). Biologically, the LIP acts as a central junction for iron trafficking, providing the necessary metal for the biogenesis of heme and iron-sulfur clusters (Dixon et al., 2012). However, an expanded LIP can trigger the Fenton reaction, generating highly reactive hydroxyl radicals that cause lipid peroxidation and initiate ferroptosis, a regulated form of cell death (Stockwell et al., 2017). Therapeutic intervention typically involves iron chelators like Deferoxamine or Deferiprone, which sequester the ferrous iron to prevent oxidative damage in diseases such as thalassemia, hereditary hemochromatosis, and various neurodegenerative disorders (Mobarra et al., 2016).
Sequestration of redox-active ferrous iron through chelation, which prevents the iron from participating in the Fenton reaction and the subsequent generation of reactive oxygen species (ROS) and lipid peroxides (Mobarra et al., 2016).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ferrous iron in the labile iron pool (LIP).